Study of Chiglitazar Compare With Placebo in Type 2 Diabetes Patients (CMAP)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02121717 |
|
Recruitment Status :
Completed
First Posted : April 23, 2014
Last Update Posted : October 25, 2019
|
Sponsor:
Chipscreen Biosciences, Ltd.
Information provided by (Responsible Party):
Chipscreen Biosciences, Ltd.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | November 2017 |
| Actual Study Completion Date : | November 2017 |